Denne siden ble automatisk oversatt og nøyaktigheten av oversettelsen er ikke garantert. Vennligst referer til engelsk versjon for en kildetekst.

Evaluation of the Temperature Difference of Medical Gases Between the Heated Inspiratory Limb and the Tracheal Carina in Patients Undergoing Invasive Mechanical Ventilation With Active Humidification: A Crossover Clinical Study.

13. november 2026 oppdatert av: Riccardo Re, Azienda Sanitaria Universitaria Integrata del Trentino

The aim of this study is to assess the actual temperature drop of medical gases from the distal end of the heated ventilator circuit to the tracheal carina during invasive mechanical ventilation with active humidification. This analysis reflects the investigators' intention to observe the temperature drop under real-world clinical practice conditions, while assessing potential interactions with patient body temperature, ambient temperature, and the size of unheated ventilatory connectors. These findings may provide insight into the appropriate temperature and humidity targets, thereby further optimizing active humidification during invasive mechanical ventilation.

Studieoversikt

Detaljert beskrivelse

Study setting: Patients undergoing invasive mechanical ventilation via orotracheal tube, nasotracheal tube, or tracheostomy cannula.

Research Hypothesis: The temperature drop between the distal end of the heated inspiratory circuit and the distal end of the tracheal tube does not exceed 2°C; therefore, heating medical gases above 37°C is not necessary.

Study Objective: 1) To assess the temperature difference between the distal end of the heated inspiratory limb and the patient's tracheal carina. 2) To identify variables that may influence the temperature drop, including connector size (dead space), the presence of a mainstream end-tidal CO₂ sensor, type, dimension and depth of tracheal tube (orotracheal, nasotracheal, tracheostomy), ventilation mode and minute volume, patient body temperature, and ambient temperature.

Study Design: Crossover clincal study Inclusion Criteria: Adult patients admitted to the Intensive Care Unit 1 of Santa Chiara Hospital in Trento, who are receiving invasive mechanical ventilation with active humidification via a tracheal tube and who already have invasive body temperature monitoring in place.

Exclusion Criteria: Patients ventilated with tracheal tubes smaller than size 7 or patients ventilated using double-lumen tubes for selective bronchial intubation.

Protocol: The study protocol involves measuring, in all patients meeting the inclusion criteria, the temperature at the end of the heated ventilator circuit ("Tpatient") and the air temperature at the level of the tracheal carina. Tpatient will be recorded as the direct reading from the humidifier display. Tracheal temperature will be measured by inserting a sterile temperature probe through the ventilator circuit. To obtain an accurate measurement of air temperature without the probe contacting the tracheal mucosa, a graduated probe will be used, calibrated according to the correct insertion depth corresponding to the tracheal tube in use. The temperature recorded by the probe will then be displayed via a dedicated electrical cable on the bedside multiparameter monitor. The heat humidifier used in the study will be the device currently available in ICU 1 of Santa Chiara Hospital in Trento, namely the Dräger Aquapor H300® humidifier. The device will be set in FREE mode, allowing the investigators to freely adjust temperature settings according to the study protocol. For each enrolled patient, two sets of measurements will be performed using different humidification settings. The first set will use a Tpatient of 37°C with a -2°C gradient (Tpatient 37°C - chamber temperature 35°C), while the second set will use a Tpatient of 40°C with a -3°C gradient (Tpatient 40°C - chamber temperature 37°C). The order in which the first or second measurement set is performed will be randomly assigned using a web-based randomization tool (random.org). Before temperature measurements are performed, correct attainment of the target humidifier temperature will be verified. For each observation, the following variables will also be recorded: age and male patient core body temperature, type of airway device, tube size, depth of tube placement, volume of unheated connectors, presence of a mainstream end-tidal CO₂ sensor, ventilation mode, minute ventilation at the time of measurement, and ambient temperature. At the end of the measurements, the probe will be removed and placed on the patient's pillow to measure the ambient temperature in the immediate vicinity of the patient.

Timeframe: The study aims to enroll 50 patients within a maximum period of one year from the first measurement.

Statistical Analysis: During the statistical analysis, the mean, standard deviation, median, and range of the temperature differences between Tpatient and the air temperature at the tracheal carina will be calculated for the two humidification settings (37°C and 40°C). These values will then be compared using the Bland-Altman method. In addition, potential correlations between temperature variations and the study's objective variables will be analysed, including core body temperature, type and size of the airway device, depth of tube placement, volume of unheated connectors, presence of a mainstream end-tidal CO₂ sensor, minute ventilation at the time of measurement, and ambient temperature.

Expected Results: The temperature drop induced by unheated ventilator connectors (catheter mount and tracheal tube/cannula) does not exceed 2°C and is influenced by both ambient temperature and patient body temperature. Accordingly, a heated inspiratory circuit temperature setting above 37°C is not necessary.

Studietype

Intervensjonell

Registrering (Antatt)

50

Fase

  • Ikke aktuelt

Kontakter og plasseringer

Denne delen inneholder kontaktinformasjon for de som utfører studien, og informasjon om hvor denne studien blir utført.

Studiekontakt

Studiesteder

    • Italy
      • Trento, Italy, Italia, 38100
        • Rekruttering
        • Santa Chiara Hospital of Trento - ASUIT
        • Ta kontakt med:

Deltakelseskriterier

Forskere ser etter personer som passer til en bestemt beskrivelse, kalt kvalifikasjonskriterier. Noen eksempler på disse kriteriene er en persons generelle helsetilstand eller tidligere behandlinger.

Kvalifikasjonskriterier

Alder som er kvalifisert for studier

18 år og eldre (Voksen, Eldre voksen)

Tar imot friske frivillige

Nei

Kjønn som er kvalifisert for studier

Alle

Beskrivelse

Inclusion Criteria: Adult patients admitted to the Intensive Care Unit 1 of Santa Chiara Hospital in Trento, who are receiving invasive mechanical ventilation with active humidification via a tracheal tube and who already have invasive body temperature monitoring in place.

Exclusion Criteria: Patients ventilated with tracheal tubes smaller than size 7 or patients ventilated using double-lumen tubes for selective bronchial intubation

Studieplan

Denne delen gir detaljer om studieplanen, inkludert hvordan studien er utformet og hva studien måler.

Hvordan er studiet utformet?

Designdetaljer

  • Primært formål: Behandling
  • Tildeling: Randomisert
  • Intervensjonsmodell: Crossover-oppdrag
  • Masking: Ingen (Open Label)

Våpen og intervensjoner

Deltakergruppe / Arm
Intervensjon / Behandling
Eksperimentell: Temperature drop 37°C

Measure of the temperarure drop in two different humidification setting: 37°C - 40°C

Evaluation of the temperature drop from the end of the heated ventilatory tube to the tracheal carina

Eksperimentell: Temperature drop 40°C

Evaluation of the temperature drop from the end of the heated ventilatory tube to the tracheal carina

Hva måler studien?

Primære resultatmål

Resultatmål
Tiltaksbeskrivelse
Tidsramme
Temperature drop
Tidsramme: 50 patients or 1 year

Measure the real temperature drop from the end of the heated respiratory tube and the tracheal carina in the patient with mechanical invasive ventilation and active humidification.

50 patients or 1 year

Samarbeidspartnere og etterforskere

Det er her du vil finne personer og organisasjoner som er involvert i denne studien.

Studierekorddatoer

Disse datoene sporer fremdriften for innsending av studieposter og sammendragsresultater til ClinicalTrials.gov. Studieposter og rapporterte resultater gjennomgås av National Library of Medicine (NLM) for å sikre at de oppfyller spesifikke kvalitetskontrollstandarder før de legges ut på det offentlige nettstedet.

Studer hoveddatoer

Studiestart (Faktiske)

22. juni 2026

Primær fullføring (Antatt)

22. juni 2027

Studiet fullført (Antatt)

22. juni 2027

Datoer for studieregistrering

Først innsendt

13. november 2026

Først innsendt som oppfylte QC-kriteriene

13. november 2026

Først lagt ut (Faktiske)

18. november 2026

Oppdateringer av studieposter

Sist oppdatering lagt ut (Faktiske)

18. november 2026

Siste oppdatering sendt inn som oppfylte QC-kriteriene

13. november 2026

Sist bekreftet

1. juni 2026

Mer informasjon

Begreper knyttet til denne studien

Andre studie-ID-numre

  • CARINA TEMP

Legemiddel- og utstyrsinformasjon, studiedokumenter

Studerer et amerikansk FDA-regulert medikamentprodukt

Nei

Studerer et amerikansk FDA-regulert enhetsprodukt

Nei

Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .

Abonnere